Structure of fragment E species from human cross-linked fibrin.
Structure of fragment E species from human cross-linked fibrin.
复制标题
人交联纤维蛋白片段 E 的结构。
DOI:
10.1021/bi00524a035
复制
发表时间:
1981
期刊:
影响因子:
2.9
通讯作者:
Greene,TC
中科院分区:
文献类型:
--
作者:
Olexa,SA;Budzynski,AZ;Doolittle,RF;Cottrell,BA;Greene,TC
Stephanie A. Olexa,* Andrei Z. Budzynski, Russell F. Doolittle, Barbara A. Cottrell, and Thomas C. Greene abstract: FragmentsEj, E2, and E3 are plasmic derivatives of fibrin encompassing the NH2-terminal region of the mol-ecule. The first two species, but not the third, can bind to fragment DD, forming a (DD) E complex, and therefore probably contain binding sites involved in the polymerization of fibrin. For localization of these sites the structure of the fragments was determined by establishing the NH2-and COOH-terminal boundaries of the molecules and using the published amino acidsequence of fibrinogen. Fragment E3 encompasses Gly-al7 to Lys-a78, Gly-015 to Lys-0122, and Tyr-71 to Lys-762, this representing the intactNH2-terminal region of fibrin. Fragment E2 is an asymmetric molecule which is lacking the sequence Gly-015 to Lys-/353 in one/3-chain remnant. This fragment E2 also lost Lys-0122 from the COOH terminal of the 0 chain as compared with fragment E^ These cleavages did not affect the ability of fragment E2 to bind to fragment DD. Fragment E3 was heterogeneous, the main species encompassing Val-a20 to Lys-a78, Lys-/354 to Leu-/3120, and Tyr-71 to Lys-753. Thus, the loss of the binding function involved in the formation offibrin clot was associated with the removal of small fragments from all three polypeptide chains: al7-19 (Gly-Pro-Arg), 015—53 from the remaining half of the molecule, 0121 (Leu), and 754-58 (Thr-Ser-Glu-Val-Lys). e study of binding sites on the fibrin molecule involved in polymerization of monomers and formation of a clot indicated that the NH2-terminal region of the parent molecule participates in this reaction. The cleavage of fibrinopeptide i From the Thrombosis Research Center and Department of Biochemistry, Temple University Health Sciences Center, Philadephia, Pennsylvania 19140 (SAO, AZB, and TCG), and the Department of Chemistry, University of California, San Diego, La Jolla, California 92093 (RFD and BAC). ReceivedDecember 23, 1980. This work was supported by Grant No. HL 14217 from the National Heart, Lung and BloodInstitute, National Institutes of Health, Bethesda, MD.